Equities

Are Litigation Finance Investments the Ultimate Diversification Tool?

As featured in this month’s Master Investor Magazine. “To reduce risk it is necessary to avoid a portfolio whose securities…

GKN driving ahead

GKN at 327p after last week’s good news on UK motor production figures... The GKN (Guest Keen & Nettlefold, as…

When Eurolander Meets Eurolander Bearing Gifts

My brief analysis of the Greek war of Interdependence and what it means for equity markets. Even without the urging…

The only rival Google fears

Microsoft changed our lives. I couldn’t have written this article without their technology, and you couldn’t read it. Some say…

The utility company that thought it was an oil and gas production company: a cautionary tale of too much ambition and enterprise

Centrica (CNA): at 270p last seen. The technical chart position looks inviting. Clearly something has to be done to put…

Is Rio Tinto a screaming buy?

The company is now generating a lot of cash and has attractive dividend paying prospects. Given that and the fact…

How sweet is the Ferrero deal for Thorntons?

Chocolate – indulgence, gift, comfort food the world over. The sweet treat is many things to many people, and a…

Cutting positions or taking a loss

Since launching the JIC Portfolio in January 2012 the portfolio is up 114.5% as of Friday 19th June 2015. I have…

Are You Feeling Lucky?

As a precursor to my Final Word article in the main magazine next month, I've been examining the firearms market…

Is the GlaxoSmithKline dividend sustainable?

GlaxoSmithKline at 1370p. This company is undergoing considerable change in its strategic objectives. It looks attractive on both market consensus…